About SyntheticMR ABSynthetic MR AB (publ) (”SyntheticMR”) was founded in Linköping, Sweden in 2007 by Dr. Marcel Warntjes in order to commercialize a new magnetic resonance image processing methodology. Dr. Warntjes’ innovation was initially developed at the Center for Medical Image Science and Visualization (CMIV), Linköping, Sweden. The uniqueness in the technology is the quantification based approach resulting in fast and informative MRI examinations based on synthetic MRI.
Founder: Marcel Warntjes
CEO: Stefan Tell
12 articles with SyntheticMR AB
In total, the Nomination Committee represents approx. 45 percent of the total number of shares and votes in the company.
SyntheticMR welcomes Dr Alex Rovira to their Medical Advisory Board to support their company with clinical expertise
SyntheticMR welcomes Dr Fritz to their Medical Advisory Board to support their product management with clinical expertise.
SyntheticMR announced that they have signed an agreement with GE Healthcare to integrate their quantitative MRI solution SyMRI in GE's platform.
SyntheticMR announced today that their quantitative imaging software solution SyMRi has received regulatory approval in Japan and can now be sold on this market.
SyntheticMR announced that they have signed an agreement with Philips Healthcare US that involves integrating SyntheticMR's imaging software solution SyMRI into the Philips product catalogue.
SyntheticMR announced that they have received a purchase order from Mayo Clinic for its medical imaging software solution SyMRI.
The SyMRI NEURO software from SyntheticMR AB and the Philips Ingenia Elition 3.0T MR scanner with the synthetic SyntAc sequence are now jointly marketed in the United States.
SyntheticMR AB 0 Segmentation and Quantification of Brain Tissue, and Industry First Myelin Volume Measurements in SyMRI Now FDA Cleared
SyMRI NEURO is the next level of quantitative MR.
SyntheticMR AB Release: Study Comparing Magic To Conventional MR Imaging Published In American Journal Of Neuroradiology (AJNR)